Valiant Laboratories Limited — Board Meeting, 11-11-2025: Outcome of Board Meeting

Valiant Labs' Board has approved its Q2 and H1 FY26 consolidated financial results. For the quarter, revenue was ₹46.20 Cr with a net profit of ₹0.20 Cr. For the half-year, revenue reached ₹93.03 Cr, yielding a net profit of ₹2.02 Cr and Basic EPS of ₹0.37.